Laboratório de Neurociências - LIM-27

< Voltar | Avançar >

Publicações

Diniz BS, Teixeira AL, Miranda AS, Talib LL, Gattaz WF & Forlenza OV. (2012) Circulating Glial-derived neurotrophic factor is reduced in late-life depression, J Psychiatr Res 46:pp. 135-139.
Machado-Vieira R, Ibrahim L, Henter ID & Zarate CAJ. (2012) Novel glutamatergic agents for major depressive disorder and bipolar disorder, Pharmacol. Biochem. Behav. 100:pp. 678-687.
Bio DS & Gattaz WF. (2011) Vocational rehabilitation improves cognition and negative symptoms in schizophrenia, Schizophr. Res.. 126:pp. 265-269.
Gattaz WF, Valente KD, Raposo NRB, Vincentiis S & Talib LL. (2011) Increased PLA2 activity in the hippocampus of patients with temporal lobe epilepsy and psychosis, J Psychiatr Res 45:pp. 1617-1620.
de Sousa RT, van de Bilt MT, Diniz BS, Ladeira RB, Portela LV, Souza DO, Forlenza OV, Gattaz WF & Machado-Vieira R. (2011) Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study, Neurosci. Lett 494:pp. 54-56.
Aprahamian I, Diniz BS, Izbicki R, Radanovic M, Nunes PV & Forlenza OV. (2011) Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains, Int J Geriatr Psychiatry 26:pp. 403-408.
Aprahamian I, Martinelli JE, Cecato J, Izbicki R & Yassuda MS. (2011) Can the CAMCOG be a good cognitive test for patients with Alzheimer’s disease with low levels of education?, Int Psychogeriatr 23:pp. 96-101.
Diniz BS, Talib LL, Joaquim HPG, de Paula VRJ, Gattaz WF & Forlenza OV. (2011) Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment?, World J. Biol. Psychiatry. 12:pp. 216-222.
Diniz BS & Teixeira AL. (2011) Brain-derived neurotrophic factor and Alzheimer’s disease: physiopathology and beyond, Neuromolecular Med. 13:pp. 217-222.
Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL & Gattaz WF. (2011) Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial, Br J Psychiatry. 198:pp. 351-356.
Forlenza OV, Torres CA, Talib LL, de Paula VJ, Joaquim HPG, Diniz BS & Gattaz WF. (2011)Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer’s disease, Psychiatr Res 45:pp. 220-224.
Machado-Vieira R & Zarate CAJ. (2011) Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments, Depress Anxiety 28:pp. 267-281.
Raposo NRB, Ferreira AS & Gattaz WF. (2011) Body mass index increase, serum leptin, adiponectin, neuropeptide Y and lipid levels during treatment with olanzapine and haloperidol, Pharmacopsychiatry 44:pp. 169-172.
Schaeffer EL, De-Paula VJ, da Silva ER, de A Novaes B, Skaf HD, Forlenza OV & Gattaz WF. (2011) Inhibition of phospholipase A(2) in rat brain decreases the levels of total Tau protein, J Neural Transm 118:pp. 1273-1279.
Schaeffer EL, Skaf HD, Novaes BDA, da Silva ER, Martins BA, Joaquim HDG & Gattaz WF. (2011) Inhibition of phospholipase A in rat brain modifies different membrane fluidity parameters in opposite ways, Prog. Neuropsychopharmacol Biol. Psychiatry 35:pp. 1612-1617.
Sortica VA, Ojopi EB, Genro JP, Callegari-Jacques S, Ribeiro-Dos-Santos A, de Moraes MO, Romano-Silva MA, Pena SDJ, Suarez-Kurtz G & Hutz MH. (2011) Influence of Genomic Ancestry on the Distribution of SLCO1B1, SLCO1B3 and ABCB1 Gene Polymorphisms among Brazilians, Basic Clin. Pharmacol. Toxicol. 46:pp. 135-139.
Belotto KCR, Raposo NRB, Ferreira AS & Gattaz WF. (2010) Relative bioavailability of two oral formulations of risperidone 2 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Brazilian volunteers, Clin Ther 32:pp. 2106-2115.
De-Paula VJ, Schaeffer EL, Talib LL, Gattaz WF & Forlenza OV. (2010) Inhibition of phospholipase A2 increases tau phosphorylation at Ser214 in embryonic rat hippocampal neurons, Prostaglandins Leukot. Essent. Fatty Acids 82:pp. 57-60.
Diniz BS, Teixeira AL, Ojopi EB, Talib LL, Mendonça VA, Gattaz WF & Forlenza OV. (2010) Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer’s disease, J. Alzheimers Dis. 22:pp. 1305-1311.
Diniz BS, Teixeira AL, Talib LL, Mendonça VA, Gattaz WF & Forlenza OV. (2010)Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression, J Psychiatr Res 44:pp. 917-920.
Diniz BS, Teixeira AL, Talib LL, Mendonça VA, Gattaz WF & Forlenza OV. (2010) Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression, World J. Biol. Psychiatry 11:pp. 550-555.
Diniz BS, Teixeira AL, Talib L, Gattaz WF & Forlenza OV. (2010) Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients, Am J Geriatr Psychiatry 18:pp. 172-176.
Forlenza OV, Diniz BS, Teixeira AL, Ojopi EB, Talib LL, Mendonça VA, Izzo G & Gattaz WF. (2010) Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment, World J. Biol. Psychiatry 11:pp. 774-780.
Pereira FS, Yassuda MS, Oliveira AM, Diniz BS, Radanovic M, Talib LL, Gattaz WF & Forlenza OV. (2010) Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement, J Int Neuropsychol Soc 16:pp. 297-305.
Schaeffer EL, da Silva ER, Novaes BDA, Skaf HD & Gattaz WF. (2010) Differential roles of phospholipases A2 in neuronal death and neurogenesis: implications for Alzheimer disease, Prog. Neuropsychopharmacol Biol. Psychiatry. 34:pp. 1381-1389.
Guimarães PEM, Fridman C, Gregório SP, Kalil EM, Cristante AF, Teixeira WGJ, Rodrigues CJ, Costa MCR, Gattaz WF, Barros TEP, Oliveira PSL & Dias-Neto E. (2009) DNA polymorphisms as tools for spinal cord injury research, Spinal Cord 47:pp. 171-175.
Mendes CT, Mury FB, de Sá Moreira E, Alberto FL, Forlenza OV, Dias-Neto E & Gattaz WF. (2009)Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease, Eur Arch Psychiatry Clin Neurosci 259:pp. 16-22.
Diniz BS, Pinto JAJ, Gonzaga MLC, Guimarães FM, Gattaz WF & Forlenza OV. (2009) To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease, Eur Arch Psychiatry Clin Neurosci 259:pp. 248-256.
Flaks MK, Forlenza OV, Pereira FS, Viola LF & Yassuda MS. (2009) Short cognitive performance test: diagnostic accuracy and education bias in older Brazilian adults, Arch Clin Neuropsychol 24:pp. 301-306.
Forlenza OV, Diniz BS, Talib LL, Mendonça VA, Ojopi EB, Gattaz WF & Teixeira AL. (2009) Increased serum IL-1beta level in Alzheimer’s disease and mild cognitive impairment, Dement Geriatr Cogn Disord 28:pp. 507-512.
Gregório SP, Sallet PC, Do K, Lin E, Gattaz WF & Dias-Neto E. (2009) Polymorphisms in genes involved in neurodevelopment may be associated with altered brain morphology in schizophrenia: preliminary evidence, Psychiatry Res 165:pp. 1-9.
Ladeira RB, Diniz BS, Nunes PV & Forlenza OV. (2009) Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly, Clinics (Sao Paulo) 64:pp. 967-973.
Schaeffer EL, Forlenza OV & Gattaz WF. (2009) Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease, Psychopharmacology (Berl.) 202:pp. 37-51.
Schaeffer EL, Novaes BA, da Silva ER, Skaf HD & Mendes-Neto AG. (2009) Strategies to promote differentiation of newborn neurons into mature functional cells in Alzheimer brain, Prog. Neuropsychopharmacol. Biol. Psychiatry 33:pp. 1087-1102.
Schmidt MT, Anghinah R, Basile LF, Forlenza O & Gattaz WF. (2009) EEG alpha peak frequency analysis during memorizing of figures in patients with mild cognitive impairment, Arq Neuropsiquiatr 67:pp. 428-431.
Talib LL, Yassuda MS, Diniz BSO, Forlenza OV & Gattaz WF. (2008) Cognitive training increases platelet PLA2 activity in healthy elderly subjects, Prostaglandins Leukot. Essent. Fatty Acids 78:pp. 265-269.
Abreu IDD, Nunes PV, Diniz BS & Forlenza OV. (2008) Combining functional scales and cognitive tests in screening for mild cognitive impairment at a university-based memory clinic in Brazil, Rev Bras Psiquiatr 30:pp. 346-349.
Diniz BSO, Pinto Júnior JA & Forlenza OV. (2008) Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer’s disease? A systematic review and meta-analysis of the literature, World J. Biol. Psychiatry 9:pp. 172-182.
Diniz BS, Nunes PV, Yassuda MS, Pereira FS, Flaks MK, Viola LF, Radanovic M, Abreu IDD, Borelli DT, Gattaz WF & Forlenza OV. (2008) Mild cognitive impairment: cognitive screening or neuropsychological assessment?, Rev Bras Psiquiatr 30:pp. 316-321.
Nunes PV, Diniz BS, Radanovic M, Abreu ID, Borelli DT, Yassuda MS & Forlenza OV. (2008) CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education, Int J Geriatr Psychiatry 23:pp. 1127-1133.
Radanovic M, Nunes PV, Gattaz WF & Forlenza OV. (2008) Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme, Psychopharmacology (Berl.) 198:pp. 1-27.
Guimarães PEM, Fridman C, Gregório SP, Kalil EM, de Barros Filho TEP, Cristante AF, Rodrigues CJ, Costa MCR, Gataz WF, Neto ED & Teixeira WGJ. (2007)WITHDRAWN: Association between polymorphisms in genes of inflammatory response and axonal repair with spinal cord injury, Spinal Cord : 30:pp. 346-349.
Ojopi EPB, Oliveira PSL, Nunes DN, Paquola A, DeMarco R, Gregório SP, Aires KA, Menck CFM, Leite LCC, Verjovski-Almeida S & Dias-Neto E. (2007) A quantitative view of the transcriptome of Schistosoma mansoni adult-worms using SAGE, BMC Genomics 8:p. 186.
Forlenza OV, Mendes CT, Marie SKN & Gattaz WF. (2007) Inhibition of phospholipase A2 reduces neurite outgrowth and neuronal viability, Prostaglandins Leukot. Essent. Fatty Acids 76:pp. 47-55.
Schaeffer EL & Gattaz WF. (2007) Requirement of hippocampal phospholipase A2 activity for long-term memory retrieval in rats, J Neural Transm 114:pp. 379-385.
Zainaghi IA, Forlenza OV & Gattaz WF. (2007)Abnormal APP processing in platelets of patients with Alzheimer’s disease: correlations with membrane fluidity and cognitive decline, Psychopharmacology (Berl.) 192:pp. 547-553.
Almeida CR, Ojopi EP, Nunes CM, Machado LR, Takayanagui OM, Livramento JA, Abraham R, Gattaz WF, Vaz AJ & Dias-Neto E. (2006)Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis, Eur Arch Psychiatry Clin Neurosci 256:pp. 307-310.
Passos Gregorio S, Gattaz WF, Tavares H, Kieling C, Timm S, Wang AG, Berg Rasmussen H, Werge T & Dias-Neto E. (2006) Analysis of coding-polymorphisms in NOTCH-related genes reveals NUMBL poly-glutamine repeat to be associated with schizophrenia in Brazilian and Danish subjects, Schizophr. Res. 88:pp. 275-282.
Wacker P, Nunes PV, Cabrita H & Forlenza OV. (2006)Post-operative delirium is associated with poor cognitive outcome and dementia, Dement Geriatr Cogn Disord 21:pp. 221-227.
Forlenza OV, Wacker P, Nunes PV, Yacubian J, Castro CC, Otaduy MCG & Gattaz WF. (2005)Reduced phospholipid breakdown in Alzheimer’s brains: a 31P spectroscopy study, Psychopharmacology (Berl.) 180:pp. 359-365.
Gregório SP, Mury FB, Ojopi EB, Sallet PC, Moreno DH, Yacubian J, Tavares H, Santos FR, Gattaz WF & Dias-Neto E. (2005) Nogo CAA 3′UTR Insertion polymorphism is not associated with Schizophrenia nor with bipolar disorder, Schizophr. Res. 75:pp. 5-9.
Mendes CT, Gattaz WF, Schaeffer EL & Forlenza OV. (2005) Modulation of phospholipase A2 activity in primary cultures of rat cortical neurons, J Neural Transm 112:pp. 1297-1308.
Schaeffer EL, Bassi FJ & Gattaz WF. (2005)Inhibition of phospholipase A2 activity reduces membrane fluidity in rat hippocampus, J Neural Transm 112:pp. 641-647.
Schaeffer EL & Gattaz WF. (2005) Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory, Psychopharmacology (Berl.) 181:pp. 392-400.
Basile LFH, Yacubian J, Ferreira BLC, Valim AC & Gattaz WF. (2004) Widespread electrical cortical dysfunction in schizophrenia, Schizophr. Res. 69:pp. 255-266.
Gattaz WF, Diehl A, Geuppert MS, Hubrich P, Schmitt A, Linde I, Maras A & Dittmann RW. (2004)Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia: a randomized double-blind trial, Pharmacopsychiatry 37:pp. 279-285.
Junqueira R, Cordeiro Q, Meira-Lima I, Gattaz WF & Vallada H. (2004)Allelic association analysis of phospholipase A2 genes with schizophrenia, Psychiatr. Genet 14:pp. 157-160.
Basile LFH, Baldo MVC, de Castro CC & Gattaz WF. (2003)The generators of slow potentials obtained during verbal, pictorial and spatial tasks, Int J Psychophysiol 48:pp. 55-65.
Fridman C, Ojopi EPB, Gregório SP, Ikenaga EH, Moreno DH, Demetrio FN, Guimarães PEM, Vallada HP, Gattaz WF & Dias Neto E. (2003)Association of a new polymorphism in ALOX12 gene with bipolar disorder, Eur Arch Psychiatry Clin Neurosci 253:pp. 40-43.
Forlenza OV, Schaeffer EL & Gattaz WF. (2002)Phospholipase A2 activity in rat embryonic brain and in primary cultures of cortical neurons, J Neural Transm 109:pp. 623-631.
Basile LFH, Ballester G, de Castro CC & Gattaz WF. (2002)Multifocal slow potential generation revealed by high-resolution EEG and current density reconstruction, Int J Psychophysiol 45:pp. 227-240.
Yacubian J, de Castro CC, Ometto M, Barbosa E, de Camargo CP, Tavares H, Cerri GG & Gattaz WF. (2002)31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism, Schizophr. Res. 58:pp. 117-122.
Meira-Lima IV, Zhao J, Sham P, Pereira AC, Krieger JE & Vallada H. (2001)Association and linkage studies between bipolar affective disorder and the polymorphic CAG/CTG repeat loci ERDA1, SEF2-1B, MAB21L and KCNN3, Mol. Psychiatry 6:pp. 565-569.
Forlenza OV, Stoppe Júnior A, Hirata ES & Ferreira RC. (2000)Antidepressant efficacy of sertraline and imipramine for the treatment of major depression in elderly outpatients, Sao Paulo Med 118:pp. 99-104.
Gattaz WF, Lara DR, Elkis H, Portela LV, Gonçalves CA, Tort AB, Henna J & Souza DO. (2000)Decreased S100-beta protein in schizophrenia: preliminary evidence, Schizophr. Res 43:pp. 91-95.
Meira-Lima IV, Pereira AC, Mota GF, Krieger JE & Vallada H. (2000)Angiotensinogen and angiotensin converting enzyme gene polymorphisms and the risk of bipolar affective disorder in humans, Neurosci. Lett 293:pp. 103-106.

Para acessar outros periódicos especializados, clique aqui.